Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Gene therapy turns the corner

Studies indicate that it is possible to achieve long-term gene transfer into hematopoietic stem cells and progenitor cells. But what needs to be done before we can take the final steps towards human stem cell gene therapy (pages 652–658)?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dick, JE, Magli, M.-C., Huszar, D., Phillips, R. & Bernstein, A. Introduction of a selectable gene into primitive stem cells capable of long term reconstitution of the hemopoietic system of W/Wv mice. Cell 42, 71–79 (1985).

    Article  CAS  Google Scholar 

  2. Brenner, M.K. Hematological malignancies. Faseb. J. 11, 640–648 (1997).

    Article  CAS  Google Scholar 

  3. Abonour, R. et al. Efficient retrovirus-mediated MDR-1 gene transfer into autologous long-term repopulating hematopoietic stem cells. Nature Med. 6, 652–658 (2000).

    Article  CAS  Google Scholar 

  4. Orkin, S. & Motulsky, A. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. http://www.nih.gov/news/panelrep.html (1995).

  5. Cavazzana-Calvo, M. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669– 672 (2000).

    Article  CAS  Google Scholar 

  6. Larochelle, A. et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy . Nature Med. 2, 1329–1337 (1996).

    Article  CAS  Google Scholar 

  7. Hanenberg, H. et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med. 2, 876–882 ( 1996).

    Article  CAS  Google Scholar 

  8. Kiem, H.P. et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor . Blood 92, 1878–1886 (1998).

    CAS  PubMed  Google Scholar 

  9. Hennemann, B. et al. High-efficiency retroviral transduction of mammalian cells on positively charged surfaces. Hum. Gene. Ther. 11 , 43–51 (2000).

    Article  CAS  Google Scholar 

  10. Guenechea, G. et al. Transduction of human CD34+CD38- bone marrow and cord blood derived SCID-repopulating cells (SRC) with third generation lentiviral vectors . Molec. Ther. 1 452–459 2000

    Article  Google Scholar 

  11. Miyoshi, H., Smith, K.A., Mosier, D.E., Verma, I.M. & Torbett, B.E. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682–686 ( 1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dick, J. Gene therapy turns the corner. Nat Med 6, 624–626 (2000). https://doi.org/10.1038/76188

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/76188

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing